AI for Prostate Cancer Imaging & Therapy Response Prediction
Nucs AI has raised $3.5M in total funding. The most recent round was Corporate Round. The last funding was announced in July 2026.
Nucs AI's investors include Segmed.
Nucs AI is headquartered in New York, United States.
AI for Prostate Cancer Imaging & Therapy Response Prediction
Nucs AI is at the Corporate Round stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nucs AI — Funding & Investors." VCBacked, July 14, 2026, https://www.vcbacked.co/company/nucs-ai. Accessed October 30, 2026.
VCBacked. (2026). Nucs AI — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/nucs-ai
{{cite web |title=Nucs AI — Funding & Investors |url=https://www.vcbacked.co/company/nucs-ai |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated